Concourse Financial Group Securities’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10642 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10265 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10274 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10085 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9873 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9634 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9204 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8579 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8090 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7666 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7243 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6952 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6754 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6636 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6547 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6385 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6358 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6217 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6131 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5970 |
|